参考文献/References:
[1] CARACENI P,DOMENIXALI M,TOVOLI A,et al.Clinical indications for the albumin use:still a controversial issue[J].European Journal of Internal Medicine,2013,24(8):721-728.
[2] FANALI G,DI MASI A,TRAZZA V,et al.Human serum albumin:from bench tobedside[J].Molecular Aspects of Medicine,2012,33(3):209-290.
[3] GARCIA-MARTINEZ R,CARACENI P,BERNARDI M,et al.Albumin:pathophysiologic basis of its role in the treatment of cirrhosis and its complications[J].Hepatology,2013,58(5):1836-1846.
[4] SITAR M E,AYDIN S,CAKATAY U.Human serum albumin and its relation withoxidative stress[J].Clinical Laboratory,2013,59(9/10):945-952.
[5] HOLLIDAY M A.Extracellular fluid and its protei-ns:dehydration,shock,and recovery[J].Pediatric Nephrology,1999,13(9):989-995.
[6] CABRERIZO S,CUADRAS D,GOMEZ-BUSTO F,et al.Serum albumin and health in older people:Review and meta analysis[J].Maturitas,2015,81(1):17-27.
[7] ONG C,HAN W M,WONG J J,et al.Nutrition biomarkers and clinical outcomes in critically ill children:A critical appraisal of the literature[J].Clinical Nutrition,2014,33(2):191-197.
[8] HAN Sheng,HUANG Yanming,LI Zhonghua,et al.The prognostic roleof preoperative serum albumin levels in glioblastoma patients[J].BMC Cancer,2015,15(1):108.
[9] GOLDWASSER P,FELDMAN J.Association of serum albumin and mortality risk[J].Journal of Clinical Epidemiology,1997,50(6):693-703.
[10] 沈丽娟,孙杰,吴晓,等.老年脓毒症患者血清清蛋白水平与其危重程度及预后的相关性[J].现代检验医学杂志,2017,32(1):131-133,137.SHEN Lijuan,SUN Jie,WU Xiao,et al.Relationship of albumin levels withthe prognosis and severity of illness among elderly sepsis patients[J].J ModLab Med,2017,32(1):131-133,137.
[11] UENO T,HIRAYAMA S,SUGIHARA M,et al.The bromocresol green assay,butnot the modified bromocresol purple assay,overestimates the serum albumin concentration in nephrotic syndrome through reaction with alpha2-macroglobulin[J].Annals of Clinical Biochemistry,2016,53(Pt 1):97-105.
[12] GARCIA MOREIRA V,BERIDZE VAKTAN-GOVA N,MARTINEZ GAGO M D,et al.Overestimation of albumin measured by bromocresol green vs bromocresol purple method:influence of acute-phase globulins[J].Laboratory Medicine,2018,49(4):355-361.
[13] MERLINI G, BLIRUP-JENSEN S, JOHNSON A M,et al.Standardizing plasmaprotein measurements worldwide:a challenging enterprise[J].Clinical Chemistry and Laboratory Medicine,2010,48(11):1567-1575.
[14] ZEGERS I,KELLER T,SCHREIBER W,et al.Cha-racterization of the new serum protein reference material ERM-DA470k/IFCC:value assignment by immunoassay[J].Clinical Chemistry,2010,56(12):1880-1888.
[15] 尚红,王毓三,申子瑜.全国临床检验操作规程[S].4版.北京:人民卫生出版社,2015:203-204.SHANG Hong,WANG Yusan,SHEN Ziyu.National guide to clinical laboratory procedures[S].4th Edition.Beijing:People's Medical Publishing House,2015:203-204.
[16] 冯品宁,姚真荣,徐鸿绪,等.免疫透射比浊法与溴甲酚绿染色法测定血清清蛋白浓度1 000例样本方法学比较及偏倚评估[J].中国卫生检验杂志,2017,27(15):2231-2234.FENG Pinning,YAO Zhenrong,XU Hongxu,et al.Determination of serum concentration of serum albumin by turbidimetric immunoassay method and bromocresol green staining method of 1 000 samples:methodological comparison and bias evaluation[J].Chin J Health Lab Tec,2017,27(15):2231-2234.
[17] 忻鼎广,石娟娟,伏春明,等.溴甲酚类试剂在测定肾病综合征和血液透析患者血清清蛋白时的偏差[J].检验医学,2006,3(21):231-233.XIN Dingguang,SHI Juanjuan,FU Chunming,et al.The deviation of serum albumin level determined by bromocresol reagent in nephrotic syndrome and hemodialyzed patients[J].Laboratory Medicine,2006,21(3):231-233.
[18] UCHIDA Y,OKUZUMI Y,FUJISHIRO M,et al.Controversies in the determination of serum albumin concentration in chronic liver diseases[J].The JapaneseJournal of Clinical Pathology,2006,54(10):1008-1012.